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Control of lymphocyte shape and the chemotactic response by the
GTP exchange factor Vav
Miguel Vicente-Manzanares, Aranzazu Cruz-Adalia, Noa B. Martı´n-Co´freces, Jose´ R. Cabrero, Mercedes Dosil,
Brenda Alvarado-Sa´nchez, Xose´ R. Bustelo, and Francisco Sa´nchez-Madrid
Rho GTPases control many facets of cell
polarity and migration; namely, the reorga-
nization of the cellular cytoskeleton to
extracellular stimuli. Rho GTPases are
activated by GTP exchange factors
(GEFs), which induce guanosine diphos-
phate (GDP) release and the stabilization
of the nucleotide-free state. Thus, the role
of GEFs in the regulation of the cellular
response to extracellular cues during cell
migration is a critical step of this process.
In this report, we have analyzed the activa-
tion and subcellular localization of the
hematopoietic GEF Vav in human periph-
eral blood lymphocytes stimulated with
the chemokine stromal cell–derived fac-
tor-1 (SDF-1). We show a robust activa-
tion of Vav and its redistribution to motil-
ity-associated subcellular structures, and
we provide biochemical evidence of the
recruitment of Vav to the membrane of
SDF-1–activated human lymphocytes,
where it transiently interacts with the
SDF-1 receptor CXCR4. Overexpression
of a dominant negative form of Vav abol-
ished lymphocyte polarization, actin poly-
merization, and migration. SDF-1–medi-
ated cell polarization and migration also
were impaired by overexpression of an
active, oncogenic Vav, although the
mechanism appears to be different. To-
gether, our data postulate a pivotal role
for Vav in the transmission of the migra-
tory signal through the chemokine recep-
tor CXCR4. (Blood. 2005;105:3026-3034)
© 2005 by The American Society of Hematology
Introduction
Leukocyte migration in and out of target tissues during homeostasis
and inflammation is a finely regulated process mediated by many
receptors, which regulate rolling, adhesion and/or detachment, and
motility. Chemotactic receptors play an important role in the
modulation of cell adhesion as well as in controlling the morphol-
ogy of migrating leukocytes.1 In particular, chemokines are chemo-
tactic cytokines that, acting through heterotrimeric G-protein–
coupled receptors (GPCRs), regulate cell adhesion through cross-
talk with integrin receptors and also modulate the morphology of
migrating leukocytes.1,2
The chemokine stromal cell–derived factor-1 (SDF-1) is the
most pleiotropic of chemokines, being involved in many processes,
from migration of hematopoietic progenitors and most leukocytes
to morphogenesis in mammals and lower organisms such as
zebrafish.3,4 SDF-1 interacts exclusively with the chemokine
receptor CXCR4, the specificity of this pair being underscored by
the similar phenotype of mice deficient for SDF-1 or CXCR4.5-7
SDF-1 has been shown to modulate adhesion through the
integrins very late activation antigen-4 (VLA-4, 41) and leuko-
cyte function associated antigen-1 (LFA-1, L2),8 although the
intracellular mechanisms involved in such cross-talk are largely
undefined. We and others have shown that SDF-1 induces
profound morphological changes in adherent leukocytes and the
acquisition of a bipolar shape with a front leading edge, in which
chemokine receptors are clustered,9-12 and a trailing edge or uropod
that accumulates adhesion molecules such as ICAM-1, -3, or CD44
(Vicente-Manzanares and Sanchez-Madrid1). CXCR4 triggering
by SDF-1 induces the activation of numerous signaling pathways,
including Ras/ERK,13 the JAK/STAT pathway,14 and PI3K-IA
and -IB.15,16 Moreover, SDF-1 induces actin polymerization in
a Rac- and Cdc42-dependent fashion17 and activates the small
GTPase RhoA.18
Small GTPases are devices controlling the actin cytoskeleton
(Etienne-Manneville and Hall19). The function of the 3 “classic”
GTPases—Cdc42, Rac, and Rho—was determined in the mid-
1990s, showing that different aspects of cell migration, such as
filopodia extension (Cdc42), lamellipodia formation (Rac), and
cell retraction and adhesion (Rho), are operated by these
molecules.20-22 Small GTPases are thus at the core of actin
regulation in migrating cells. However, the mechanisms by
which SDF-1 triggers GTPase activation are largely unclear.
Some reports have demonstrated that SDF-1 induces ZAP-70
activation,23,24 which is an upstream activator of Vav. Vav
belongs to the Dbl family of GTP exchange factors (GEF),
which favor GTP exchange for GDP, thus rendering the GTPase
active (Bustelo25 and Turner and Billadeau26).
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The Vav subfamily is composed of 3 different genes: Vav1,
which is restricted to hematopoietic cells; and Vav2 and Vav3,
whose expression pattern is broader.27,28 The 3 of them are involved
in lymphocyte ontogeny (Bustelo25 and Turner and Billadeau26),
and there seems to be some degree of redundancy among them; for
example, Vav2 can compensate Vav1 in some contexts, such as
B-cell development and function.29 However, redundancy is not
absolute; for instance, Vav1-deficient mice have lower numbers of
T cells, due to defective pre–T-cell receptor (pre–TCR) signaling,
that cannot be replaced by Vav2, which does not seem to participate
in T-cell ontogeny.30 Regarding their ability to activate small
GTPases, it seems that Vav1 is primarily a GEF for Rac,31 whereas
Vav2 and Vav3 would act on Rho.28,32 Their ability to activate
Cdc42 is controversial.33
To avoid aberrant signaling to the GTPases, these molecules are
finely regulated. In the case of Vav, tyrosine phosphorylation of
specific residues induces exposure of the GTPase binding site.34
Thus, Vav appears a likely candidate to mediate signal transduction
from CXCR4 to the actin cytoskeleton and therefore control
lymphocyte morphology.
In this report, we demonstrate Vav activation by SDF-1 in
human primary lymphocytes (peripheral blood leukocytes [PBLs]),
as well as inducible association of Vav to CXCR4. Furthermore, the
expression of Vav mutants defective in Rac activation impaired cell
polarization and migration, further reinforcing the involvement of
Vav in CXCR4-mediated signal transduction. On the other hand,
overexpression of an oncogenic, constitutively activated form of
Vav in human PBLs prevented cell polarization in response to
SDF-1, demonstrating that fine tuning of Vav activation is a
requirement for lymphocyte polarization in response to chemo-
kines, thus highlighting the role of Vav in dynamic responses of
migratory cells to extracellular chemotactic cues.
Materials and methods
Reagents
Rabbit polyclonal anti-Vav and anti–phospho-Tyr174 Vav (pY174) have
been described elsewhere.34 Mouse monoclonal anti–intercellular adhesion
molecule 3 (ICAM-3) antibody HP2/19 (IgG2a, ) was previously de-
scribed.35 Mouse monoclonal anti–human CXCR4 antibody 12G5 (IgG1,
) and fluorescein isothiocyanate (FITC)–conjugated anti–mouse CD3 and
anti–mouse B220 were from Pharmingen BD (Mountain View, CA). Rabbit
polyclonal anti–human CXCR4 antibody for immunoprecipitation experi-
ments, anti-FLAG, and human fibronectin were from Sigma Chemical (St
Louis, MO). Polyclonal anti–human CD69 and 90/3, which recognize
CD69 and ezrin/radixin/moesin (ERM) proteins, respectively, have been
described elsewhere.35,36 SDF-1 was from R&D Systems (Minneapolis,
MN). GFP-Vav WT, GFP-Vav (1-186) and untagged Vav (1-186) have
been previously described.37 GFP-Vav L213Q and GFP-Vav (1-186)
L213Q were obtained from their nonmutated counterparts by site-directed
mutagenesis employing QuickChange mutagenesis kit (Stratagene, Cedar
Creek, TX), employing the following primers: 5-GAGGAGAAGTATACA-
GACACACAGGGCTCCATCCAGCAGCACTTC-3 and 3-GAAGTGCT-
GCTGGATGGAGCCCTGTGTGTCTGTATACTTCTCCTC-5 (Qiagen
Operon GmbH, Cologne, Germany). Introduction of the expected mutation
was confirmed by automated DNA sequencing (Centro de Investigaciones
Biolo´gicas, Madrid, Spain). GFP-Rac1 wild type and GFP-G12V Rac1
have been described elsewhere.38 Alexa 647-phalloidin was from Molecular
Probes (Eugene, OR).
PBL purification
PBLs were purified as described elsewhere.15 Briefly, freshly prepared
buffy coats from healthy donors were subjected to gradient centrifugation
on Histopaque-1077 (Sigma), followed by 3 rounds of plastic adherence to
remove monocytes. Populations were shown to contain less than 2%
monocytes as shown by staining with anti-CD14. Approval was obtained
from the Hospital Universitario de la Princesa Institutional Review Board
for these studies. Informed consent was provided according to the
Declaration of Helsinki.
Immunofluorescence and confocal microscopy
Indirect immunofluorescence assays were performed as described.15 Briefly,
cells were fixed with 4% paraformaldehyde in phosphate-buffered saline
(PBS) containing 2 M sucrose and 2 mM MgCl2 for 10 minutes at room
temperature and stained for 30 minutes with anti–ICAM-3 or anti-CXCR4
at 37°C followed by incubation with a 1:200 dilution of anti–mouse IgGs
coupled to rhodamine red-X (Jackson Immuno Research Laboratories, West
Grove, PA). Cells were then permeabilized in 0.5% Triton X-100  2%
paraformaldehyde in PBS for 5 minutes, followed by incubation with either
rabbit anti-Vav or anti–phospho-Tyr174 Vav and staining with highly
cross-absorbed anti–rabbit IgGs coupled to Alexa 488. Cells were observed
using a Leica DMR photomicroscope (Leica, Mannheim, Germany) with a
100 /1.40-0.7 OIL CS objective, coupled to a COHU 4912-5010 CCD
Camera (COHU, San Diego, CA). The acquisition software was Leica
QFISH V2.1, and images were processed with Adobe Photoshop 7.0. For
quantification of cell polarization, at least 300 transfected cells were
counted in 4 independent experiments as assessed by ICAM-3 redistribu-
tion and formation of 2 well-defined morphological poles.15 Quantitative
analysis of cell spreading was performed with ImageJ software (National
Institutes of Health, Bethesda, MD) in at least 50 transfected cells from 3
independent experiments, as described.39
Immunoprecipitation experiments and Western blot
For analysis of Vav phosphorylation, 107 PBLs were stimulated with 10 nM
SDF-1 for the times indicated, rinsed twice in ice-cold Hanks balanced
salt solution (HBSS), and lysed in buffer containing 1% Triton X-100, 10
mM MgCl2, 1 mM Na3VO4, 10 mM NaF, 1 mM phenylmethylsulfonyl
fluoride (PMSF), and COMPLETE cocktail inhibitor tablets (Roche
Boehringer, Mannheim, Germany).
For immunoprecipitation, 50  106 PBLs were resuspended in RPMI
1640 medium containing 0.1% bovine serum albumin (BSA) at 37°C. Cells
were then stimulated with 10 nM SDF-1 for the times indicated, rinsed
twice in ice-cold HBSS, and lysed in buffer containing 1% Brij-96 and
complemented as previous protocol. Cell lysates were clarified by centrifu-
gation at 20 000g for 15 minutes at 4°C, and protein content in the cell
lysates was measured before the pull-down using a protein detection kit
(BioRad, Hercules, CA). For analysis of Vav phosphorylation, lysates were
mixed with 3  Laemmli buffer and subjected to sodium dodecyl sulfate–
polyacrylamide gel electrophoresis (SDS-PAGE). For immunoprecipita-
tion, protein extracts were precleared by overnight incubation with 50 L
protein A-agarose (Amersham, Arlington Heights, IL), centrifuged (15 000g,
1 minute), and immunoprecipitated overnight with the CXCR4 pAb
coupled to 50 L protein A-agarose. The sepharose pellet was washed 5
times with lysis buffer and resuspended in 3  Laemmli buffer. Samples
were resolved by SDS-PAGE and transferred to nitrocellulose membrane,
blocked with 5% BSA for 30 minutes, and blotted against CXCR4 and Vav
(or phosphoTyr174 Vav where indicated), followed by rabbit IgGs coupled
to horseradish peroxidase (HRP). Chemiluminescence was developed with
SuperSignal reagent (Pierce, Rockford, IL).
Mice
Vav1-deficient C57/BL10 mice40 were kindly provided by Dr V. Ty-
bulewicz (National Institute for Medical Research, London, United King-
dom) and kept in the animal facility of the Centro de Investigacio´n del
Ca´ncer (Salamanca). Control littermates were from Charles River Laborato-
ries (Wilmington, MA). Mice were processed according to institutional
guidelines in compliance with international laws and policies. T-cell
populations isolated from spleen and lymph nodes were decreased in both
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the spleens and lymph nodes of Vav1-deficient mice (50% 	 5% vs
22% 	 8%, n 
 8 in each case), in agreement with previous reports.40
Migration assay
Migration assays were performed in Boyden-modified chambers (Trans-
well, Costar, Cambridge, MA) as described elsewhere.18 Quantification of
cell migration was performed by counting transfected and nontransfected
cells in a FACScalibur flow cytometer (Becton Dickinson, Mountain View,
CA) for 60 seconds. Fluorescence intensity was determined in a FACScali-
bur flow cytometer. Four cell subsets were defined according to green
fluorescent protein (GFP) expression (NULL, LOW, MEDIUM, and
HIGH), and the percentage of migrating cells was calculated for each
expression interval as previously described.41
F-actin determination assay
Determination of the levels of polymerized actin was performed as
described.17 Briefly, lymphocytes from wild-type or Vav1-deficient mice or
PBLs from buffy coats were collected as described and resuspended in
prewarmed RPMI 1640 medium at 2  106/mL, and 100 L of cells were
incubated or not with 10 nM SDF-1 at 37°C for 20 seconds. Then, cells
were fixed and permeabilized with 200 L of CELLwash buffer (Becton
Dickinson) for 10 minutes at 4°C and incubated for 30 minutes at 4°C with
5 g/mL of Alexa 647-conjugated phalloidin. For Vav/ and Vav/ mice
lymphocytes, FL4 (Alexa 647) fluorescence intensity was determined in
either CD3 or B220 gated cells in a FACScalibur flow cytometer. The
relative increase in the level of F-actin was calculated as described in.17
PBL nucleofection
Transfection of human PBLs was performed as follows: 12  106 cells
were washed twice in ice-cold sterile PBS and resuspended in 100 L
nucleofection T-cell buffer (Amaxa Biosystems, Cologne, Germany). A
total amount of 12 g of the indicated cDNA was added and subjected to
the U-14 nucleofection program in an Amaxa Nucleofector I. Cells were
resuspended in 4 mL RPMI 1640 supplemented with 10% FBS without
antibiotics. Expression efficiency was measured 24 hours after nucleofec-
tion, and cells were employed in the experiments indicated.
Rac activation assay
GST-PAK-CRIB, which recognizes active Rac and Cdc42, was kindly
donated by Dr John Collard (The Netherlands Cancer Institute, Amsterdam)
and was prepared as described.42 Pull-down experiments were performed as
follows: 5  106 of CXCR4-CFP stably expressing HEK-293 cells, kindly
provided by Dr M. Mellado (Centro Nacional de Biotecnologı´a, Madrid),
were transfected with the calcium phosphate precipitation method with the
different constructs of Vav and stimulated for 10 minutes with 10 nM
SDF-1. Following incubation, the cells were washed twice with ice-cold
HBSS and lysed at 4°C in buffer containing 50 mM Tris (tris(hydroxymethyl)
aminomethane), pH 7.4, 100 mM NaCl, 10% glycerol, 1% Nonidet-P40, 2
mM MgCl2, 1 mM PMSF, 2 mM benzamidine, and COMPLETE cocktail
inhibitor tablets (Roche Boehringer Mannheim, Indianapolis, IN). Cell
lysates were clarified by centrifugation at 20 000g for 15 minutes at 4°C.
The protein content in the cell lysates was measured before the pull-down
using a protein detection kit (BioRad, Hercules CA). Equal amounts of
protein were incubated with beads coupled GST-PAK-CRIB for 60 minutes
at 4°C then washed 4 times in lysis buffer, resuspended in Laemmli buffer,
separated in 15% SDS-PAGE, and transferred to nitrocellulose membranes.
Western blot was performed using antibodies against Rac followed by a
HRP-conjugated antimouse serum. Detection of chemiluminescence was
performed using SuperSignal Pico detection kit from Pierce. Protein
loading was controlled using the protein detection kit and by Western blot
of one tenth of the sample loaded on a separate blot. For statistical purposes,
gels of active and total Rac were subjected to densitometric analysis and
normalized with respect to the loading control. Arbitrary units obtained for
each condition were then referred to the value of the untreated, GFP-
transfected cells to obtain fold induction.
Results
Activation of Vav by SDF-1 in human PBL
Activation of Vav by SDF-1 has been previously suggested in Vav
immunoprecipitates of leukemic cell lines by means of the 4G10
antibody, which recognizes phosphorylated tyrosine residues.24
However, it has been shown that only phosphorylation of some
tyrosine residues of Vav, such as Tyr174, are bona fide indicators of
GEF activation.34 To unequivocally determine whether SDF-1
induced activation of Vav, freshly isolated PBLs from healthy
donors were stimulated with 10 nM SDF-1 (the dose that induces
maximal chemotactic activity in T cells15), and immunoblotting
analysis was carried out with a polyclonal antibody that specifically
recognizes Vav phosphorylated at residue Tyr174 (pY174). A
time-dependent phosphorylation of Vav was observed in SDF-1–
treated PBLs, which was detectable after 5 minutes of stimulation,
reaching a plateau until 20 minutes, and declining thereafter
(Figure 1A-B).
It has been previously reported that adhesion of Jurkat T cells to
fibronectin induces Vav phosphorylation, thus decreasing the pool
of Vav that can be phosphorylated by other stimuli.43 To ascertain
whether lymphocyte adhesion affected the extent to which SDF-1
can phosphorylate Vav, studies were performed similar to that
Figure 1. SDF-1 induces phosphorylation of Tyr174 of Vav in human PBLs.
(A) Human PBLs in suspension were treated for the indicated time points with 10 nM
(100 ng/mL) SDF-1, lysed and blotted with a polyclonal antibody against phospho-
Tyr174 (pY174) Vav. The same membrane was stripped and reblotted against total
Vav. A representative experiment of 4 performed is shown. (B) Kinetics of SDF-1–
induced Vav phosphorylation in human PBLs. Fold induction of pY174 Vav compared
to untreated cells and corrected to total Vav is shown. Results represent the
mean 	 SEM of 4 independent experiments. (C) Human PBLs were allowed to
spread on 50 g/mL fibronectin or to remain in suspension and were stimulated with
10 nM SDF-1, lysed and treated as in panel A. A representative experiment and its
quantitative analysis of 4 performed is shown. (D) Dose-response of SDF-1–
induced Vav phosphorylation in human PBLs. Human PBLs were allowed to spread
on 50 g/mL fibronectin or to remain in suspension and were stimulated with the
indicated dose of SDF-1 for 10 minutes, lysed, and treated as in panel A.
Quantitative analysis of 4 independent experiments performed is shown. Data
represent the mean 	 standard deviation. (E) Dose-response of SDF-1–induced
human PBL migration. Human PBLs were allowed to migrate for 3 hours in
Boyden-modified chemotaxis chambers in the presence of the indicated doses of
SDF-1 (E) or RANTES (regulated upon activation normal T cell expressed and
presumably secreted; F), used as a control, and migration was quantified by flow
cytometry as stated in “Materials and methods.” Data represent the mean 	 standard
deviation of 4 independent experiments performed in triplicate.
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shown in Figure 1A and comparing SDF-1–stimulated cells either
in suspension or adhered to human fibronectin. Interestingly, we
found that adhesion by itself induced a 3-fold phosphorylation of
Vav, which was further enhanced by addition of SDF-1 up to
6-fold (Figure 1C).
Dose-response experiments showed that the dose of chemo-
attractant required for maximal phosphorylation of Vav (Figure
1D) is within the range of 5 to 10  109 M (5-10 nM, 50-100
ng/mL) in adhered cells as well as in the case of suspended cells,
which is in the same range of the maximal induction of chemotaxis
and cell polarization by this chemokine (Figure 1E and Vicente-
Manzanares et al15). Together, our data indicate that the Vav
phosphorylation induced by integrin ligation is complementary to
that induced by chemoattractants, pointing to a role for this
molecule in both signaling pathways.
Polarized activation of Vav and interaction with the
chemokine receptor CXCR4
The subcellular localization of Vav upon activation with SDF-1 in
human PBLs was studied by indirect immunofluorescence experi-
ments on fibronectin. We found that SDF-1 induced cell polariza-
tion as previously described,15 and a strong redistribution of the
adhesion molecule ICAM-3 to the uropod of migrating cells
compared to adhered cells untreated with SDF-1 (Vicente-
Manzanares et al15 and Figure 2). Vav adopted a bipolar distribution
at both the leading edge (LE) and the cell uropod (U), although no
obvious colocalization with ICAM-3 was observed (Figure 2). In
addition, Vav was shown to be active at both localizations as
demonstrated by staining with the antibody recognizing Tyr174-
phosphorylated Vav, which suggested that SDF-1 induced Vav
activation and redistribution is important for its function in the
control of the morphology of migrating cells.
We and others have previously shown that the chemokine CXCR4 is
partially clustered at the leading edge of migrating cells during the
chemotactic response.9-12 Since Vav was clustered at the leading edge of
SDF-1–responding cells, we studied its possible interaction with
CXCR4. Indirect immunofluorescence experiments with either anti-Vav
or anti–phospho-Tyr174 Vav suggested their partial colocalization in
SDF-1–stimulated cells (Figure 3A, arrowheads in insets). Remark-
ably, strong biochemical evidence was provided by CXCR4 immunopre-
cipitates of SDF-1–stimulated PBLs, in which we found a clear-cut
Figure 2. SDF-1 induces a bipolar distribution of Vav and its activation at the
leading edge of human PBLs. Human PBLs were allowed to adhere to 50 g/mL
fibronectin and treated or not with 10 nM (100 ng/mL) for 30 minutes, fixed, and
stained for ICAM-3 (red) and either pY174 Vav or total Vav (green). Representative
fields are shown. LE, leading edge; U, uropod.
Figure 3. SDF-1 promotes association of Vav to the chemokine receptor
CXCR4. (A) Human PBLs were allowed to adhere to 50 g/mL fibronectin and treated
or not with 10 nM (100 ng/mL) SDF-1 for 30 minutes, fixed, and stained for CXCR4
(red) and either pY174 Vav or total Vav (green). Yellow spots represent colocalization
of CXCR4 and either pY174 Vav or total Vav. Representative fields are shown. LE,
leading edge; U, uropod; arrowheads, colocalization. (B) Human PBLs in suspension
were treated for the indicated time points with 10 nM (100 ng/mL) SDF-1, lysed, and
CXCR4 immunoprecipitated with a specific rabbit polyclonal antibody. A rabbit
polyclonal antibody against human CD69 was employed as specificity control.
Samples were resolved by SDS-PAGE and blotted against Vav and CXCR4. Fold
induction represents the amount of Vav found in CXCR4 immunoprecipitates
compared to that in nonstimulated cells. A representative experiment and its
quantitative analysis of 3 performed is shown. (C) Human PBLs in suspension were
treated for 10 minutes with 10 nM (100 ng/mL) SDF-1, lysed, and Vav immunopre-
cipitated with a specific rabbit polyclonal antibody against Vav. A rabbit polyclonal
antibody against human ERM proteins (90/3) was employed as specificity control.
Samples were separated by SDS-PAGE and blotted against CXCR4 and Vav. Fold
induction represents the amount of CXCR4 found in Vav immunoprecipitates
compared to that in nonstimulated cells. A representative experiment and its
quantitative analysis are shown.
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SDF-1–dependent interaction of Vav with CXCR4 (Figure
3B). Such biochemical interaction was further confirmed by
reciprocal immunoprecipitation, in which we were able to detect
CXCR4 in Vav immunoprecipitates (Figure 3C). This fact
suggests that CXCR4 probably recruits Vav to the membrane as
part of a putative signalosome to transmit signals to the actin
cytoskeleton and may regulate the morphology of the cell.
Lymphocytes from Vav1-deficient mice are not defective in
responses to SDF-1
Vav1-deficient mice have proved a useful tool to dissect the role of
GEFs in the development of the immune system and its re-
sponses.40,44,45 To assess the ability of Vav1-deficient lymphocytes
to respond to SDF-1, we isolated T and B cells from spleens, as
well as T cells from lymph nodes of wild-type and Vav1/ mice
and analyzed their response to SDF-1. Apparently, no major
defect was detected on the chemotactic response of Vav1-deficient
lymphocytes compared to lymphocytes from control littermates
(Figure 4A), in agreement with previous results.46 Furthermore, we
found no significant difference on SDF-1–induced F-actin in-
crease induced by chemokines (Figure 4B), thus suggesting that
lymphocytes from Vav1/ overcome the lack of this molecule by
alternative molecular pathways.
A dominant negative form of Vav impairs lymphocyte
polarization
To investigate the role of Vav in the regulation of lymphoid
chemotaxis and cell shape, we obtained different forms of Vav1
fused to GFP (Figure 5A). These constructs exert different effects
on Rac activation when overexpressed in HEK-293 cells bearing
the SDF-1 receptor CXCR4. We found that Vav wild type induced
a 2-fold increase in the levels of GTP-bound Rac, which was more
pronounced in the case of the oncogenic Vav (1-186) form
(Figure 5B). On the other hand, overexpression of a mutated form
of Vav, Vav L213Q, which has been described to impair Rac
signaling, virtually abrogated CXCR4-dependent Rac activation
(Figure 5B), which postulates a central role for Vav in this
signaling cascade, thus confirming the functional effects of Vav
on Rac activation.
Human PBLs were nucleofected with the constructions indi-
cated (Figure 5A), allowed to adhere to fibronectin in the presence
of 10 nM SDF-1, and stained for the polarization marker
ICAM-3. Remarkably, overexpression of GFP-Vav L213Q, which
has been shown not to interact with Rac1, thus interrupting Rac1
signaling,37 resulted in abrogated cell polarization monitored by
ICAM-3 redistribution to the uropod (Figure 5C,E). However, the
distribution of the mutated molecule was very similar to that of
wild-type Vav, suggesting its normal recruitment to the membrane
(Figure 5C, green). As control, nucleofection of either GFP or
GFP-Vav wild type exerted a negligible effect on SDF-1–induced
cell polarization (Figure 5E). These data indicate that Vav L213Q
interrupts the signaling from CXCR4 to the actin cytoskeleton that
is required to initiate cell polarization, likely by inhibiting further
signal transduction to small monomeric GTPases, namely Rac.
Overexpression of oncogenic Vav impairs cell polarization by a
mechanism different from Vav L213Q
A mutant of Vav lacking its N-terminus, Vav (1-186), has been
shown to possess oncogenic potential and to ectopically activate
the small GTPase Rac1 (Figure 5B and Zugaza et al37). To assess its
effect on PBL polarization induced by SDF-1, the GFP-Vav
(1-186) fusion protein was overexpressed by nucleofection. Vav
(1-186) impaired cell polarization induced by SDF-1 (Figure
5D-E). To gain insight on the mechanism by which Vav (1-186)
inhibits cell polarization, we performed similar experiments with
another mutant Vav (1-186) L213Q, which is almost identical to
Vav (1-186) but does not interact with Rac1. This mutant showed
no effect on cell polarization induced by SDF-1 (Figure 5D-E),
which demonstrates that the inhibitory effect of Vav (1-186) is
dependent on downstream activation of Rac1 and concurs with
previous results from our group and others showing that overexpres-
sion of active Rac1 impairs cell polarization.38 In addition, we
found that Vav (1-186) consistently increased the levels of
polymerized (F-) actin in human PBLs, whereas SDF-1–induced
actin polymerization was not observed in PBLs expressing Vav
L213Q (Figure 5F), which further support that Vav (1-186) and
Vav L213Q impair cell polarization by completely different
mechanisms.
Regarding the effect of Vav on the morphology of the cell,
although it has been repeatedly demonstrated that ectopic Rac1
activation by Rac-GEF or activated Rac overexpression induces
cell spreading,38 no such spreading was observed in Vav (1-186)–
expressing PBLs (Figure 5D). Conversely, overexpression of
constitutively activated Rac1 (G12V) in PBL induced cellular
spreading and the formation of large actin-based ruffles (Figure
6A), which suggested that perhaps the amount of Rac1 in PBLs was
lower than in other cell types, thus constituting the limiting step in
cell spreading. To address this issue, we performed co-expression
experiments in which PBLs were simultaneously nucleofected with
Rac1 wild type and Vav (1-186). We found that Rac1 by itself
induced no spreading, which was greatly enhanced in cells
co-expressing both molecules (Figure 6A-B), thus suggesting that
Figure 4. Lymphocytes from Vav1-deficient mice do not show defects on
SDF-1–induced cell migration and F-actin increase. (A) Mouse lymphocytes
were isolated from spleen or lymph nodes (LN) of wild-type (WT; ) or Vav1/-
deficient mice (KO; f) and allowed to migrate for 3 hours in 3-m pore diameter
Boyden-modified migration chambers in the presence of 10 nM SDF-1. Transmi-
grated as well as control cells were stained for CD3 or B220 surface molecules
respectively and quantified by flow cytometry. Results correspond to the mean 	 SEM
of the percentage of transmigrated cells per condition. Wild type, n 
 8; Vav1/-
deficient, n 
 8. Experiments were performed in triplicate. (B) Mouse lymphocytes
were isolated from spleen or lymph nodes (LN) of wild type or Vav1/-deficient mice,
stimulated with 10 nM SDF-1 for 20 seconds (f) or not (), stained for F-actin with
Alexa488-conjugated phalloidin, and F-actin content evaluated by flow cytometry.
Results correspond to the mean fold induction 	 SEM. Wild type, n 
 8; Vav1/-
deficient, n 
 8. Experiments were performed in triplicate.
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Rac was actually the limiting molecule for spreading and that
overcoming this limitation resulted in enhanced spreading.
Overexpression of dominant negative or oncogenic Vav
impairs chemotaxis
To investigate whether lymphocyte shape changes resulted in
impaired cell migration, chemotaxis experiments were performed
in Boyden-modified chemotaxis chambers (Figure 7), defining
expression gates as previously described.41 We found that none of
the constructs exerted any effect on cell migration at low expres-
sion. However, Vav (1-186) inhibits chemotaxis to SDF-1 at
medium expression levels, which was more evident when high
levels of the molecule were expressed (Figure 7). In addition,
overexpression of Vav L213Q at high levels resulted in abrogated
chemotaxis, which demonstrates a dose-dependent inhibition of
chemotaxis by these Vav constructs and further underscores the
role of Vav in the chemotactic response.
Discussion
Small GTPases are crucial mediators of cytoskeletal-based shape
changes in eukaryotic cells, and their regulation appears as a
fundamental step to control complex processes such as cell
migration. Directional migration, on the other hand, requires
sustained extracellular cues, normally adopting the form of a
gradient, soluble or immobilized, which implies 2 fundamental
issues: (1) amplification of the signal provided by the gradient;
and (2) continuous intracellular cycling of the signaling interme-
diates to ensure a maintained response.47 It is well known that
small GTPases cycle between active and inactive state; such
cycling depends on both translocation of the small GTPase to
the subcellular location where it exerts its biologic effect and
also on interactions with catalytic activators or inhibitors.19
Regulation of the first step is now being unveiled by advances in
Figure 5. Oncogenic as well as dominant negative Vav impairs SDF-1–induced human PBL polarization. (A) Schematics of the constructs employed in these assays.
(B) CXCR4-expressing HEK-293 cells were transfected with the indicated Vav constructs, stimulated for 10 minutes with 10 nM SDF-1, pull-down experiments were
performed with GST-PAK-CRIB construct (which recognizes GTP-bound Rac), and SDS-PAGE–resolved samples were blotted with anti-Rac antibody. A representative
experiment of 3 performed is shown. Fold induction has been corrected to the amount of Rac present in the total lysates. (C) Human PBLs were nucleofected with GFP-Vav
L213Q and allowed to adhere for 30 minutes to 50 g/mL fibronectin in the presence of 10 nM (100 ng/mL) of SDF-1 for 30 minutes, fixed, and stained for ICAM-3 (red).
Representative fields are shown. (D) Human PBLs were nucleofected with GFP-Vav(1-186) or GFP-Vav human PBLs were nucleofected with GFP-Vav(1-186) or GFP-Vav
(1-186) L213Q and treated as in panel C. Representative fields are shown. (E) Quantitative analysis of the experiments shown in panels A and B. More than 300 cells per
condition have been analyzed in 4 independent experiments. (F) Human PBLs were nucleofected with the indicated Vav constructs, stimulated with 1 (10 ng/mL; u) or 10 nM
(100 ng/mL; f) of SDF-1 for 30 seconds or not (), fixed, and stained for polymerized F-actin, which was subsequently measured by flow cytometry. Data represent the
mean 	 standard deviation of 3 experiments performed in triplicate. CH, calponin homology; Ac, acidic domain; DH (GEF), Dbl homology guanosine exchange factor; PH,
pleckstrin homology; SH, Src homology; ZF, zinc finger.
Figure 6. Regulation of spreading of PBLs on fibronec-
tin by Vav and Rac. (A) Human PBLs were transfected
with the indicated constructions and stained for either Vav
(red) or actin (blue). Representative cells are shown.
(B) Quantitative analysis of the experiments shown in
panel A. More than 50 cells per condition were analyzed
with ImageJ for area quantification. Data represent the
mean 	 SD.
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our understanding of the mechanisms that retain the molecule on
the cytoplasm48 or its interaction with second messengers that
provide positional information, such as phospholipids or site-
restricted phosphorylation.49 Such processes are usually coordi-
nated, that is, GEFs can be phosphorylated at specific cellular
locations, thus rendering the GTPase active within that location.
In agreement with this notion, this work shows that the
chemokine SDF-1 induced tyrosine phosphorylation of the
GEF Vav at Tyr174, a residue that has been consistently shown
to regulate Vav activity; as such phosphorylation destroys the
intramolecular interaction of the N-terminus of Vav with its
C-terminus, which allows the Rac binding site to remain hidden
and inactive. This is a more consistent indicator of Vav
activation than those experiments in which Vav is immunopre-
cipitated and total phosphotyrosine revealed, as Vav can be
phosphorylated in other tyrosine residues, whose implication in
Vav activation is not so clear, even leading to its down-
modulation.34 Phosphorylation of Vav at this residue is likely to
be dependent of ZAP-70, since this kinase has been described to
activate Vav in leukemic cells.24 Vav phosphorylation occurs in
response to different extracellular stimuli, that is, growth
factors, adhesion, etc. For cell migration to occur, 2 signals are
required, which are cell adhesion and a promigratory stimulus. It
has been previously shown that adhesion of Jurkat T cells to
fibronectin induces Vav phosphorylation.43 Consistent with this,
we found fibronectin-induced Tyr174 Vav phosphorylation in
human PBLs. In addition, SDF-1 induced further phosphoryla-
tion of Vav at Tyr174, which suggests that adhesion per se is not
able to induce maximal activation of Vav during cell migration,
which is achieved by the combination of adhesive and chemoat-
tractant stimuli.
Furthermore, we found that phosphorylated Vav is restricted to
the leading edge of migrating cells and to the trailing edge or
uropod. Activated Vav at the leading edge probably regulates its
formation and perpetuation inducing the local activation of Rac and
thus actin polymerization through a WAVE/Scar-Arp2/3–depen-
dent mechanism50,51 and/or relaxation of myosin-dependent tension
by Pak-dependent phosphorylation of myosin-II heavy chain,52 but
the role of Vav activation at the uropod is currently unknown.
However, Vav activation at the uropod may be a consequence of its
interaction with the Syk kinase, which is an upstream regulator of
Vav.53 In this regard, Syk kinase is recruited to the uropod, where it
associates to an ITAM-like motif within ERM adaptor proteins.54
Thus, it is likely that Vav activation at the uropod may occur at
adhesion molecule–dependent signalosomes including both ERMs
and Syk. However, we have been unable to detect Vav in
immunoprecipitates of adhesion molecules clustered at the uropod
of the cell (data not shown). Therefore, it is likely that Vav presence
in the uropod of the cell is associated with the formation of actin
cables at the trailing edge of the cell, which are involved in
adhesion turnover and retraction. On the other pole of the cell,
SDF-1 induces colocalization and biochemical association of Vav
with the chemotactic receptor CXCR4. We have previously shown
that this also occurs for type IA PI 3-kinase,15 thus we can speculate
that, following SDF-1 stimulation, a signalosome is formed under
CXCR4, which recruits signaling intermediates that transmit the
chemotactic signal to the actin cytoskeleton. Vav would be
included in such a signalosome, but it is unlikely that it directly
interacts with CXCR4, since no Pro-rich domain (that might
interact with the SH3 domain of Vav) or consensus phosphorylated
Tyr (for interaction with the SH2 domain) have been described in
the cytoplasmic tail of CXCR4.
Contrary to what occurs in the GRK-dependent complex, actin
polymerization–inducing complexes are mainly dependent on
heterotrimeric inhibitory G (Gi) proteins, since pertussis toxin–
treated cells are still able to undergo CXCR4 internalization but not
actin polymerization.55,56 It is interesting to note that Vav still
remains biochemically bound to CXCR4 when Vav phosphoryla-
tion is declining (20 minutes), which suggests the existence of in
situ signal limitation processes that switch off Vav prior to its
dissociation from the receptor. In this regard, both CXCR4 and Vav
have been shown to interact with different membrane and cytoplas-
mic phosphatases, which may play a role in signal turn-off.57,58
The role of Vav in the propagation of CXCR4 signaling to the
cytoskeleton is highlighted by overexpression of a GEF-deficient
form of Vav, in which the critical residue for interaction with Rac
has been point-mutated. This form is still recruited to the mem-
brane but blocks the polarizing response to SDF-1 as well as PBL
migration to the chemokine.
In recent years, cells from Vav-deficient mice have proved
useful tools to explore the immunobiology of these molecules.
Having access to Vav1-deficient mice, we performed ex vivo
migration and actin polymerization experiments with T and B cells
from such mice. These mice showed reduced numbers of T cells, as
previously described,40 but were devoid of other obvious defects.
Cell polarization experiments proved extremely difficult to per-
form, probably due to the lack of an appropriate integrin-dependent
substrate, although monocyte spreading, which occurs spontane-
ously and in the absence of integrin-dependent interactions, was
unaffected in Vav1-deficient cells (data not shown). A range from
0.1 nM to 1 M SDF-1 was assayed with no significant
differences in lymphocyte migration or F-actin increase responses
to SDF-1. It is likely that these lymphocytes have overcome the
Vav1 defect, probably employing Vav2 or Vav3 instead for
CXCR4-dependent responses. Our data with dominant negative
forms of Vav suggest that this mutant binds to the interaction site of
Vav in the putative CXCR4 signalosome, thus blocking further
interaction of other Vav members, which are given free access in
the case of the Vav1-deficient lymphocytes.
A previous report clearly showed that overexpression of an
activated mutant of Rac1 blocked leukemic cell polarization due to
increased and omnidirectional cell spreading.38 Consistent with
this, overexpression of Vav (1-186) resulted in abrogated cell
polarization, but rather unexpectedly, it did not induce cell
spreading, whereas the activated mutant of Rac1, V12Rac, induced
Figure 7. Oncogenic as well as dominant negative Vav impairs SDF-1–
induced human PBL migration. Human PBLs were nucleofected with the indicated
GFP-fusion proteins (, GFP; u, Vav WT; p, Vav 1-186; and f, Vav L213Q) and
after 24 hours were allowed to migrate for 3 hours in 3-m pore diameter
Boyden-modified migration chambers in the presence of 10 nM SDF-1. Cells were
gated and analyzed according to their expression of the GFP-fusion protein. Results
correspond to the mean 	 SEM of the percentage of transmigrated cells per
condition in 4 independent experiments performed in triplicate; NO TR, non-
transfected.
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a modest, round-shaped cell spreading. However, the fact that V12
Rac was actually able to induce spreading together with the fact
that PBLs contained comparable amounts of actin to leukemic cells
(data not shown) made unlikely that the amount of actin within
PBLs was responsible for the spreading defect. To determine
whether other components could be limiting this response, we
overexpressed wild-type Rac together with Vav (1-186), finding
that this combination enhanced PBL spreading, allowing us to
postulate that the spreading defect was caused by a limiting amount
of Rac in PBLs.
Together, our data demonstrate the key role of Vav proteins in
the chemotactic response and provide a functional link between
chemokine triggering and lymphocyte polarization and migration
in response to extracellular cues.
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